Announcements Trials

Browse Landscape

Phase

Phase NA 11 Phase 2 5 Phase 4 2 Phase 1/2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

OTHER 85 INDUSTRY 45 NIH 34 NETWORK 34 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Breast Neoplasms 17 Uterine Cervical Neoplasms 11 Stomach Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Ovarian Neoplasms 8 Neoplasms 8 Esophageal Neoplasms 8 Carcinoma, Ovarian Epithelial 7 Fallopian Tube Neoplasms 6 Colorectal Neoplasms 5 Recurrence 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Mouth Neoplasms 4 Head and Neck Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Hepatocellular 4 Rectal Neoplasms 3 Nasopharyngeal Carcinoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Glioblastoma 3 Esophageal Squamous Cell Carcinoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Peripheral Nervous System Diseases 2 Melanoma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2

Interventions

Platelet Transfusion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER_GOV × Lymphoma × Clear all

NCT01642563 2015-07-28

IPTAS

Centro Nazionale Sangue

Phase 3 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡